Key Highlights

  • Auna tumbled after changing its Earnings outlook.
  • It now expects full-year adjusted EBITDA to be broadly stable or slightly down.
  • The company cited pressure in Colombia.
  • Health care was the second-worst S&P 500 sector.

A softer outlook

Auna S.A. (NYSE:AUNA) tumbled on Wednesday, with the stock among the notable decliners on the NYSE Composite same-day market recap. The catalyst was a change in the company's earnings outlook.

Auna now expects full-year adjusted EBITDA to be broadly stable or slightly down, and the company cited pressure in Colombia. Adjusted EBITDA, short for earnings before interest, taxes, Depreciation and amortization, is a measure many investors use to gauge a company's operating profitability before financing costs and accounting charges. A flatter or lower outlook for that figure can prompt analysts to reconsider their estimates and valuations.

The direction of the stock, however, was clearly lower.

What Auna does

Auna is a health care company with operations in Latin America, including Colombia, where it runs medical facilities and related services. Its shares trade in New York, making it one of a number of foreign companies that are part of the NYSE Composite.

Health care providers operating across several countries face a mix of local regulatory systems, payment structures and currency movements. When one market comes under pressure, it can weigh on the group's overall results, which appears to be what Auna signaled with its outlook.

A rough day for health care

Auna's decline came on a difficult day for the health care sector broadly. Health care was the second-worst sector in the S&P 500 on Wednesday, behind only energy. Much of that weakness was driven by US health insurers, which sold off for a second straight day after the Centers for Medicare & Medicaid Services proposed a rule expanding Medicare Advantage audits. UnitedHealth (NYSE:UNH) was the worst performer in the Dow, and Humana (NYSE:HUM) was the worst in the S&P 500.

That proposal applies to the US Medicare program and does not directly concern Auna's Latin American business. Still, the sector-wide selling added to a negative tone for health care stocks.

Market backdrop

The broader market was mixed. The S&P 500 slipped 16.90 points to 7,323.63, its fifth straight loss and its longest losing streak since June. The Dow fell 561.25 points to 50,198.17, while the Nasdaq Composite rose 101.50 points to 24,429.88 and the Russell 2000 added 12.44 points to 2,714.31.

Decliners outnumbered advancers on the New York Stock Exchange 1,641 to 1,205.

Interest rates and the dollar were also in focus. Minutes from the Federal Reserve's October meeting showed almost all participants judged further increases in the federal funds rate "would likely be appropriate." The US dollar traded near its strongest level since April 2025. A stronger dollar can reduce the value of earnings generated in other currencies when they are translated back, which can be a consideration for companies reporting in dollars but operating abroad.

Colombia Pressure Reshapes Auna's Earnings Outlook

Investors will be watching for more detail from Auna on the pressure it cited in Colombia, including how long management expects it to last and what steps the company may take in response. Performance in its other markets, cost controls and any updates to the outlook will also be closely followed.

The company's next Quarterly Report will be the next major checkpoint. Analyst estimate revisions after the outlook change could also shape trading in the coming sessions, as could moves in Latin American currencies against a strong US dollar and the Federal Reserve's Dec. 8-9 meeting.